Immunoglobulin Subclass Deficiency

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2021-09-29
Clinical Trial Update: Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis [Phase 4]
Phase 4 trial investigating immunoglobulin replacement for IgG subclass 2 deficiency with bronchiectasis has been withdrawn.